Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM411881 (US10392391, Compound I-O-26 | US10787452, Compound...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vertex Pharmaceuticals Incorporated US Patent | Assay Description Compounds were screened for their ability to inhibit ATR kinase using a radioactive-phosphate incorporation assay. Assays were carried out in a mixtu... | US Patent US10392391 (2019) BindingDB Entry DOI: 10.7270/Q2CF9SGQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM411881 (US10392391, Compound I-O-26 | US10787452, Compound...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
VERTEX PHARMACEUTICALS INCORPORATED US Patent | Assay Description Assays were carried out at 25° C. in the presence of 5 nM full-length ATR. An assay stock buffer solution was prepared containing all of the reagents... | US Patent US10787452 (2020) BindingDB Entry DOI: 10.7270/Q2M90CRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM411881 (US10392391, Compound I-O-26 | US10787452, Compound...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | UniChem | US Patent | <10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were screened for their ability to inhibit ATR kinase using a radioactive-phosphate incorporation assay. Assays were carried out in a mixtu... | Citation and Details BindingDB Entry DOI: 10.7270/Q2639SW3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM411881 (US10392391, Compound I-O-26 | US10787452, Compound...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Table 5: Compounds were screened for their ability to inhibit ATR kinase using a radioactive-phosphate incorporation assay. Assays were carried out i... | Citation and Details BindingDB Entry DOI: 10.7270/Q2MP56GR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase ATR (Homo sapiens (Human)) | BDBM411881 (US10392391, Compound I-O-26 | US10787452, Compound...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | UniChem | 600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details BindingDB Entry DOI: 10.7270/Q2CN782F | ||||||||||||
More data for this Ligand-Target Pair |